Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2008
09/24/2008CN101270147A Achyranthes bidentata polypeptide, preparing process and uses
09/24/2008CN101270146A Method for preparing aflatoxin G1 artificial antigen
09/24/2008CN101269214A Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
09/24/2008CN101269111A Method for extracting alpha-diastase restrainer from phaseolus limensis
09/24/2008CN101269092A Snake venom cytotoxin, preparation method and application thereof
09/24/2008CN100420752C Disinsection gene and purpose thereof
09/24/2008CN100420751C Pesticidal gene and its use
09/24/2008CN100420750C Chinese prawn C-type agglutinin gene and its coded C-type agglutinin peptide and uses
09/23/2008US7427696 Transcription factor stress-related proteins and methods of use in plants
09/23/2008US7427677 Expression of zebrafish bone morphogenetic protein 4
09/23/2008US7427671 DNA sequence which code human platelet derived growth factor receptor proteins which preferentially binds to dimers of platelet derived growth factors with high receptivity
09/23/2008US7427669 antibodies which recognizes membrane glycoprotein (ULBP) for use in treatment and prevention of cell proliferative disorders; immunotherapy
09/23/2008US7427668 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response
09/23/2008US7427667 monoclonal; humanized; fragments; labeled
09/23/2008US7427663 Cardio myopeptidin, the production and the use thereof
09/23/2008US7427662 treating non-cancerous diseases which symptoms include an increase in angiogenesis, e.g., psoriasis, retinopathy of prematurity, neovascular glaucoma, diabetic retinopathy, obesity
09/23/2008US7427661 canine interleukin -5 protein for use in identifying immunomodulators which treat or prevent autoimmune, allergic, infectious, inflammatory and graft rejection disorders in animals
09/23/2008US7427660 Tumor antigen
09/23/2008US7427659 Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction
09/23/2008US7427658 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
09/23/2008US7427657 Aromatic sulfenates for type 1 phototherapy
09/23/2008US7427656 Peptide tags for the expression and purification of bioactive peptides
09/23/2008US7427655 Synthetic immunogenic but non amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid deposits
09/23/2008US7427603 Method of enhancing proliferation and/or hematopoietic differentiation of stem cells
09/23/2008US7427598 Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory
09/23/2008US7427597 Method of treating brain tissue damages
09/23/2008US7427596 Having mutations in the Kinase domain region (KDR) and/or the FMS-like Tyrosine-Kinase region (FLT-1), said variants exhibiting modified binding characteristics at said regions compared with native VEGF; stimulates vasculogenesis or angiogenesis; wound healing
09/23/2008US7427595 Use of proepithelin to promote wound repair and reduce inflammation
09/23/2008US7427594 Methods and pharmaceuticals compositions for treating coronary artery disease, ischemia,and vascular disease using angiopoietins
09/23/2008US7427592 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia
09/23/2008US7427590 Neurothrophic components of the ADNF I complex
09/23/2008US7427498 Composition, methods and reagents for the synthesis of a soluble form of human PHEX
09/23/2008US7427495 Enhancing or inhibiting apoptosis
09/23/2008US7427494 Nucleotide sequences coding cytokine receptor for identifying modulators for treating blood disorders associated with cancer treatment
09/23/2008US7427488 Purified and isolated platelet calcium channel nucleic acids and polypeptides and therapeutic and screening methods using same
09/23/2008US7427487 for the direct identification of candidate compounds such as receptor agonists, inverse agonists, partial agonist or antagonist for use in graft rejection; inflammatory skin disease; inflammatory bowel disease; allergic inflammation, pulmonary inflammation, inflammatory demyelinating neuropathy
09/23/2008US7427486 Mullerian inhibiting substance levels and ovarian response
09/23/2008US7427485 Method for classification of anti-psychotic drugs
09/23/2008US7427484 Polypeptides, nucleic acids; gene codes; antibiotic, immunosuppressants; identifying a novel secondary metabolite biosynthesis gene cluster in a fungus
09/23/2008US7427476 Using hypermethylation of T-type calcium channel(CACNA1G) gene sequences as diagnostic indicator of cell proliferative disorders; calcium channel blocker and cancer treatment
09/23/2008US7427404 immunologically active and having reduced or no toxicity; decreased histamine sensitivity activity
09/23/2008US7427403 Administering a soluble lymphotoxin- beta receptor, an antibody directed against LT- beta receptor, or an antibody directed against surface LT ligand with a carrier; multiple sclerosis, vision defects, psoriasis, inflammatory bowel disease; antidiabetic agents
09/23/2008US7427399 Antibodies and related molecules that bind to 161P2F10B proteins
09/23/2008US7427397 Vitamin B12 supplement comprising Propionibacterium jensenii 702 together with a delivery agent; tuberculosis
09/23/2008US7427392 Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
09/23/2008CA2445687C Compositions, methods and systems for the discovery of enediyne natural products
09/23/2008CA2346797C Process for recovering heterologous polypeptides from bacterial cells
09/23/2008CA2332126C A novel human thrombopoietin mutein
09/23/2008CA2294598C Transcriptional activators with graded transactivation potential
09/23/2008CA2290863C Plant transformation methods
09/23/2008CA2259940C High-affinity interleukin-4 muteins
09/23/2008CA2206008C Method for the synthesis of analogs of parathyroid hormone and parathyroid hormone related peptide
09/23/2008CA2187283C Circularly permuted ligands and circularly permuted chimeric molecules
09/23/2008CA2186004C Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules
09/23/2008CA2163256C Adenoviral vectors of animal origin and use thereof in gene therapy
09/23/2008CA2143125C Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein
09/23/2008CA2139430C Polypeptides having serotoninergie activity (5ht5a), nucleic acids coding for these polypeptides and uses thereof
09/23/2008CA2118373C Method to reverse the phenotype of transformed cells by the transcription factor irf-1
09/18/2008WO2008112987A1 Treating skin cancer
09/18/2008WO2008112840A2 Novel composition and methods for the treatment of immune related diseases
09/18/2008WO2008112736A1 Tighter-binding c-peptide inhibitors of hiv-1 entry
09/18/2008WO2008112729A2 TRICHODERMA REESEI α -AMYLASE IS A MALTOGENIC ENZYME
09/18/2008WO2008112514A1 He4 monoclonal antibodies and methods for their use
09/18/2008WO2008112344A2 Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
09/18/2008WO2008112258A2 Modified proteases
09/18/2008WO2008112017A2 Avian influenza vaccine
09/18/2008WO2008112008A2 Sensor proteins and assay methods
09/18/2008WO2008112007A1 Immunoreactive glycoprotein gp19 of ehrlichia canis
09/18/2008WO2008111634A1 Biomarker specific to brain/nerve or specific to neuronal differentiation
09/18/2008WO2008111430A1 METHOD FOR PRODUCING γδT CELL POPULATION
09/18/2008WO2008111343A1 Method for analysis of epitope
09/18/2008WO2008110695A1 Novel multimeric molecules, method for preparing same and use thereof in the preparation of drugs
09/18/2008WO2008110653A1 Antibody producing microorganism, elements required to obtain same, resulting antibodies, therapeutic compositions and use of thereof
09/18/2008WO2008110627A1 Novel vaccine composition for the treatment of respiratory infectious diseases
09/18/2008WO2008110356A2 Protein pi 16 secreted from the heart and uses thereof
09/18/2008WO2008110332A1 Peptide-complement conjugates
09/18/2008WO2008110325A2 Probiotic
09/18/2008WO2008110303A1 Novel gene useful for growth control of plants
09/18/2008WO2008110301A1 Aprotinin variants with improved properties
09/18/2008WO2008110073A1 Improving cold- and salt-tolerant performance of plants with transcription factor gene snac2 from rice
09/18/2008WO2008110004A1 Reoviruses having modified sequences
09/18/2008WO2008109976A1 Kunitz-type recombinant inhibitor
09/18/2008WO2008086042A3 Preventing infection by a measles or respiratory syncytial virus
09/18/2008WO2008085406A3 Modified live (jmso strain) haemophilus parasuis vaccine
09/18/2008WO2008076255A3 Canine thymic stromal lymphopoietin protein and uses thereof
09/18/2008WO2008074813A3 Optiogenin for the treatment of neural diseases
09/18/2008WO2008073617A3 Increasing tolerance of plants to low light conditions
09/18/2008WO2008070816A3 Staphylococcal two helix binding protein
09/18/2008WO2008060596A9 Enhanced protein production in t. reesei by co-expression of selected genes
09/18/2008WO2008059005A3 Novel sequences of haemonchus contortus, immunogenic compositions, methods for preparation and use thereof
09/18/2008WO2008049865A3 Methods for increasing the resistance in plants to biotropic fungi
09/18/2008WO2008049070A3 Il-17c antagonists and methods of using the same
09/18/2008WO2008048942A3 Receptor(sstr2)-selective somatostatin antagonists
09/18/2008WO2008045505A3 Compositions, methods and kits for isolating nucleic acids from body fluids using anion exchange media
09/18/2008WO2008045437A3 Chimeric t-cell receptors and t-cells targeting egfrviii on tumors
09/18/2008WO2008032073A3 Novel nematode protein and its use in producing anthelminthic agents and vaccines
09/18/2008WO2008027560A3 Holin-enhanced vaccines and reagents, and methods of use thereof
09/18/2008WO2008011446A3 Human glp-1 mimetibodies, compositions, methods and uses
09/18/2008WO2007047518A3 Polynucleotides encoding lignin biosynthetic pathway enzymes in coffee
09/18/2008US20080229454 Method For The Production Of Gamma-Linolenic Acid And/Or Stearidonic Acid In Transgenic Brassicaceae And Linaceae